Royal Marsden appoints new managing director
Compiled by Philip Housden
Mark Hawken
Royal Marsden NHS Trust has announced Mark Hawken has been appointed managing director of The Royal Marsden Private Care. He follows Shams Maladwala who left the role in early 2023 for Dubai.
Mark joins from the London Clinic, where he had been commercial director since 2018. In this role, he was responsible for building private care revenue as well as implementing new services and partnerships with clinicians and other healthcare organisations.
After beginning his healthcare career as a pharmacist, Mark has also held senior commercial roles for Bupa and Aspen Healthcare, including responsibility as a turnaround specialist and hospital director for Aspen.
He said: ‘I am delighted to join The Royal Marsden Private Care, a world-class cancer centre with a reputation for pioneering innovative research and providing outstanding care and treatment.
‘I very much look forward to supporting the growth of the organisation’s integrated private service, which provides benefits for patients and staff across the whole hospital.’
The trust’s published 2022-23 annual accounts show growth in private patient income of £162.2m, up 14.5% and £20.5m on the £141.6m achieved in 2021-22.
The two-year growth in bounce-back from Covid has been 37% and £60m. Royal Marsden Private Care maintains its strong position as the NHS trust with the highest grossing private patient income and highest percentage of total income from this source. That figure remains over one-third at 34.2% last year.
Central London trusts report private patient growth
Final private patient revenues growth rates in the 2022-23 financial year for the ten central London NHS trusts was 22.8%, in line with the forecast made in last month’s PPU Watch.
Nine of the ten reported growth, the exception being Imperial College which had a small decline of 2.7% and £1m.
King’s College also had a positive year, with growth of 71.5% and £3.9m to reach £9.35m. The full reports are summarised above.
Philip Housden is director of Housden Group commercial healthcare consultancy